Global Longlife Hospital and Research Limited
ListedSMEHealthcare · BSE
Global Longlife Hospital and Research Limited is an NABH-accredited multi-speciality tertiary care hospital based in Ahmedabad, Gujarat, offering a wide range of healthcare services including oncology, ophthalmology, cardiology, dermatology, gynecology, spine and plastic surgery, dialysis, physiotherapy, ultrasound, and microbiology. The hospital has a capacity of 110 well-equipped beds supporting both medical and surgical specialties, and as of December 31, 2021, it is supported by 11 full-time consultants, over 30 experienced consulting doctors, 37 nurses, and more than 50 paramedical, pharmacy, corporate, and support staff, ensuring comprehensive and quality patient care.
Price Band
₹140
Issue Size
₹49.00 Cr
Lot Size
1000 shares
GMP
₹1
+0.7%
Est. Listing
₹141
at current GMP
Subscribed
—
Open
21 Apr 2022
Close
25 Apr 2022
Allotment
30 Apr 2022
Refund
1 May 2022
Demat Credit
2 May 2022
Listing
4 May 2022
Last updated 12 days ago
Live Grey Market Premium
Global Longlife Hospital and Research Limited GMP Today
Last updated: 19 Oct 2026
Current Premium
₹1+0.7%
Issue Price (Upper)
₹140
Band: ₹140
Estimated Listing Price
₹141
Upper price + GMP
Lot Size
1000 shares
Min investment ₹1,40,000
Estimated Profit / Lot
₹1,000
1000 × ₹1
Global Longlife Hospital and Research Limited GMP Historical Trend
GMP History
Grey Market Premium trend
+₹1
▲ 0 today
Updated 1 minute ago
Estimated Listing Price
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹1 | 0.7% | ₹141 |
| 30 Oct 2026 | +₹1 | 0.7% | ₹141 |
| 29 Oct 2026 | +₹1 | 0.6% | ₹141 |
GMP is unofficial market data. Not a guarantee of listing performance.
About Global Longlife Hospital and Research Limited Public Issue & Market Profile
Global Longlife Hospital and Research Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹49 Crores. The shares are offered at a price band of ₹140 to ₹140 per equity share on BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Public Issue & Pricing Context:
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1000 shares (approx. ₹1,40,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Basis of Allotment & Listing Timeline:
Allotment reconciliation will be managed by Bigshare Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2022-05-02, while un-allotted funds or UPI block mandates will be released on 2022-05-01.
Frequently Asked Questions
What is Global Longlife Hospital and Research Limited IPO GMP today?
The latest grey market premium for Global Longlife Hospital and Research Limited IPO is ₹1, which indicates an expected listing price of ₹141.
What does Kostak Rate and Sauda mean in IPO GMP?
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
Is Grey Market Premium officially recognized?
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.